Tags

Type your tag names separated by a space and hit enter

Medium-term results of ultrasound-guided foam sclerotherapy for small saphenous varicose veins.
Br J Surg. 2009 Nov; 96(11):1268-73.BJ

Abstract

BACKGROUND

The results of surgery for small saphenous varicose vein (SSV) varicosities may be suboptimal in terms of recurrence and complications. The role of minimally invasive alternatives remains incompletely defined. The aim was to review the medium-term outcomes of ultrasound-guided foam sclerotherapy (UGFS) for SSV.

METHODS

Eighty-six patients (92 legs) undergoing UGFS for SSV were assessed before, and 1, 6 and 12 months after treatment. Outcome measures were occlusion of, and abolition of reflux in, the SSV (technical success), absence of visible varicose veins (clinical success) and improvement in disease-specific health-related quality of life (HRQL) following treatment (Aberdeen Varicose Vein Symptom Severity Score (AVSS)).

RESULTS

The technical and clinical success rates at 12 months were 91 and 93 per cent respectively; only three patients required a second treatment. After treatment of isolated SSV varicosities there was a significant improvement in AVSS, from a median of 19.0 (interquartile range 13.4-26.8) before treatment to 10.2 (4.0-18.3) and 9.7 (3.5-19.1) at 6 and 12 months respectively. The only complication was a popliteal vein thrombosis that required anticoagulation.

CONCLUSION

UGFS was an effective treatment for SSV, with abolition of reflux and visible varicose veins, and improvement in HRQL for at least 12 months.

Authors+Show Affiliations

Birmingham University Department of Vascular Surgery, Heart of England NHS Trust, Birmingham, UK. katydarvall@btinternet.comNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article

Language

eng

PubMed ID

19847863

Citation

Darvall, K A L., et al. "Medium-term Results of Ultrasound-guided Foam Sclerotherapy for Small Saphenous Varicose Veins." The British Journal of Surgery, vol. 96, no. 11, 2009, pp. 1268-73.
Darvall KA, Bate GR, Silverman SH, et al. Medium-term results of ultrasound-guided foam sclerotherapy for small saphenous varicose veins. Br J Surg. 2009;96(11):1268-73.
Darvall, K. A., Bate, G. R., Silverman, S. H., Adam, D. J., & Bradbury, A. W. (2009). Medium-term results of ultrasound-guided foam sclerotherapy for small saphenous varicose veins. The British Journal of Surgery, 96(11), 1268-73. https://doi.org/10.1002/bjs.6755
Darvall KA, et al. Medium-term Results of Ultrasound-guided Foam Sclerotherapy for Small Saphenous Varicose Veins. Br J Surg. 2009;96(11):1268-73. PubMed PMID: 19847863.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Medium-term results of ultrasound-guided foam sclerotherapy for small saphenous varicose veins. AU - Darvall,K A L, AU - Bate,G R, AU - Silverman,S H, AU - Adam,D J, AU - Bradbury,A W, PY - 2009/10/23/entrez PY - 2009/10/23/pubmed PY - 2009/12/16/medline SP - 1268 EP - 73 JF - The British journal of surgery JO - Br J Surg VL - 96 IS - 11 N2 - BACKGROUND: The results of surgery for small saphenous varicose vein (SSV) varicosities may be suboptimal in terms of recurrence and complications. The role of minimally invasive alternatives remains incompletely defined. The aim was to review the medium-term outcomes of ultrasound-guided foam sclerotherapy (UGFS) for SSV. METHODS: Eighty-six patients (92 legs) undergoing UGFS for SSV were assessed before, and 1, 6 and 12 months after treatment. Outcome measures were occlusion of, and abolition of reflux in, the SSV (technical success), absence of visible varicose veins (clinical success) and improvement in disease-specific health-related quality of life (HRQL) following treatment (Aberdeen Varicose Vein Symptom Severity Score (AVSS)). RESULTS: The technical and clinical success rates at 12 months were 91 and 93 per cent respectively; only three patients required a second treatment. After treatment of isolated SSV varicosities there was a significant improvement in AVSS, from a median of 19.0 (interquartile range 13.4-26.8) before treatment to 10.2 (4.0-18.3) and 9.7 (3.5-19.1) at 6 and 12 months respectively. The only complication was a popliteal vein thrombosis that required anticoagulation. CONCLUSION: UGFS was an effective treatment for SSV, with abolition of reflux and visible varicose veins, and improvement in HRQL for at least 12 months. SN - 1365-2168 UR - https://www.unboundmedicine.com/medline/citation/19847863/Medium_term_results_of_ultrasound_guided_foam_sclerotherapy_for_small_saphenous_varicose_veins_ L2 - https://doi.org/10.1002/bjs.6755 DB - PRIME DP - Unbound Medicine ER -